Cogent Biosciences (COGT) EBT Margin (2017 - 2020)
Cogent Biosciences' (COGT) quarterly EBT Margin came in at 20362.82% in Q3 2020, down 1899086.0% year-on-year from N/an in Q4 2019, and down 1352.91% on a QoQ basis from 1401.52% in Q2 2020.
Cogent Biosciences (COGT) EBT Margin (2017 - 2020) Analysis & Trends
Cogent Biosciences (COGT) has 4 years of EBT Margin data on file, last reported at 20362.82% in Q3 2020.
- On a quarterly basis, EBT Margin fell 1899086.0% year-over-year to 20362.82% in Q3 2020; TTM through Dec 2020 was 1133.54%, a 96620.0% decrease from a year earlier, with the FY2020 full-year figure at 1090.23%, down 91881.0% from the prior year.
- EBT Margin for Q3 2020 stood at 20362.82%, down from 1401.52% in the prior quarter.
- Over the last five years, EBT Margin for COGT reached as high as 9.62% in Q4 2019 and fell as low as 20362.82% in Q3 2020.
- Historically, EBT Margin has averaged 1814.3% across 4 years, with a median of 364.25% in 2017.
- On a YoY basis, EBT Margin climbed as much as 32594 bps in 2020 and fell as far as 1899086 bps in 2020.
- Year by year, EBT Margin stood at 364.25% in 2017, then grew by 25 bps to 274.22% in 2018, then surged by 104 bps to 9.62% in 2019, then tumbled by 211873 bps to 20362.82% in 2020.
- Per Business Quant data, the three most recent EBT Margin figures were 20362.82% in Q3 2020, 1401.52% in Q2 2020, and 86.67% in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17.13% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 41.95% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 23.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 34.77% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cogent Biosciences | 6.87 Bn | 6.87 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -20,362.82% |
| Jun 30, 2020 | -1,401.52% |
| Mar 31, 2020 | -86.67% |
| Dec 31, 2019 | 9.62% |
| Sep 30, 2019 | -1,371.96% |
| Jun 30, 2019 | -399.24% |
| Mar 31, 2019 | -412.61% |
| Dec 31, 2018 | -274.22% |
| Sep 30, 2018 | -597.99% |
| Jun 30, 2018 | -682.95% |
| Mar 31, 2018 | -345.32% |
| Dec 31, 2017 | -364.25% |
| Sep 30, 2017 | -306.78% |
| Jun 30, 2017 | -290.52% |
| Mar 31, 2017 | -327.26% |